Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,550 | 106 | 99.6% |
| Education | $14.81 | 2 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Cook Medical LLC | $594.24 | 5 | $0 (2024) |
| Astellas Pharma US Inc | $431.64 | 29 | $0 (2023) |
| Boston Scientific Corporation | $300.96 | 4 | $0 (2024) |
| PFIZER INC. | $273.51 | 12 | $0 (2023) |
| Ambu Inc. | $241.55 | 2 | $0 (2024) |
| NeoTract Inc. | $176.94 | 3 | $0 (2019) |
| Endo Pharmaceuticals Inc. | $154.96 | 9 | $0 (2023) |
| Calyxo, Inc. | $140.65 | 1 | $0 (2024) |
| KARL STORZ Endoscopy-America | $137.47 | 1 | $0 (2023) |
| Coloplast Corp | $124.36 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $514.57 | 6 | Calyxo, Inc. ($140.65) |
| 2023 | $696.76 | 13 | KARL STORZ Endoscopy-America ($137.47) |
| 2022 | $320.11 | 12 | Cook Medical LLC ($135.86) |
| 2021 | $245.36 | 14 | Astellas Pharma US Inc ($58.36) |
| 2020 | $92.43 | 6 | PFIZER INC. ($46.88) |
| 2019 | $405.10 | 19 | Astellas Pharma US Inc ($136.63) |
| 2018 | $797.32 | 32 | Cook Medical LLC ($227.30) |
| 2017 | $493.19 | 6 | NeoTract Inc. ($122.65) |
All Payment Transactions
108 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/14/2024 | Ambu Inc. | — | Food and Beverage | Cash or cash equivalent | $122.34 | General |
| 12/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $90.51 | General |
| Category: NEUROSCIENCE | ||||||
| 11/07/2024 | Calyxo, Inc. | CVAC ASPIRATION SYSTEM (Device) | Food and Beverage | In-kind items and services | $140.65 | General |
| Category: Urology | ||||||
| 10/01/2024 | Cook Medical LLC | COOK (Device) | Food and Beverage | Cash or cash equivalent | $101.40 | General |
| Category: Urology | ||||||
| 03/19/2024 | Boston Scientific Corporation | LithoVue (Device) | Food and Beverage | In-kind items and services | $37.59 | General |
| Category: LithoVue_URO | ||||||
| 01/17/2024 | C. R. Bard, Inc. & Subsidiaries | Bard Urinary Drainage Bag (Device) | Food and Beverage | In-kind items and services | $22.08 | General |
| Category: Urology | ||||||
| 11/01/2023 | Axonics, Inc. | Axonics (Device) | Food and Beverage | In-kind items and services | $114.75 | General |
| Category: Urology | ||||||
| 10/12/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $14.17 | General |
| Category: Urology | ||||||
| 08/15/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $14.14 | General |
| Category: Urology | ||||||
| 07/22/2023 | Endo Pharmaceuticals Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $21.75 | General |
| Category: UROLOGY | ||||||
| 07/14/2023 | Coloplast Corp | Titan (Device) | Food and Beverage | In-kind items and services | $17.06 | General |
| Category: Men's Health | ||||||
| 06/27/2023 | PFIZER INC. | XTANDI (Drug), ORGOVYX, COMIRNATY | Food and Beverage | In-kind items and services | $29.28 | General |
| Category: ONCOLOGY | ||||||
| 06/23/2023 | Ambu Inc. | — | Food and Beverage | Cash or cash equivalent | $119.21 | General |
| 06/23/2023 | Tolmar, Inc. | ELIGARD (Drug) | Food and Beverage | In-kind items and services | $22.24 | General |
| Category: Prostate Cancer | ||||||
| 06/21/2023 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $133.43 | General |
| Category: General - Kidney Stone Disease_URO | ||||||
| 06/15/2023 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $24.70 | General |
| Category: Oncology | ||||||
| 05/25/2023 | Endo Pharmaceuticals Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $23.87 | General |
| Category: UROLOGY | ||||||
| 04/20/2023 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $24.69 | General |
| Category: Oncology | ||||||
| 02/21/2023 | KARL STORZ Endoscopy-America | Flex-X (Device) | Food and Beverage | In-kind items and services | $137.47 | General |
| Category: UROLOGY | ||||||
| 10/06/2022 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | In-kind items and services | $26.29 | General |
| Category: Interventional Urology | ||||||
| 09/26/2022 | PFIZER INC. | XTANDI (Drug), ORGOVYX, PAXLOVID | Food and Beverage | In-kind items and services | $19.46 | General |
| Category: ONCOLOGY | ||||||
| 09/23/2022 | Boston Scientific Corporation | General - Kidney Stone Disease (Device) | Food and Beverage | In-kind items and services | $13.83 | General |
| Category: General - Kidney Stone Disease_URO | ||||||
| 08/11/2022 | ConvaTec Inc. | GENTLECATH (Device) | Food and Beverage | In-kind items and services | $13.91 | General |
| Category: CONTINENCE CARE | ||||||
| 08/01/2022 | ABBVIE INC. | LUPRON DEPOT (Drug) | Education | In-kind items and services | $13.50 | General |
| Category: ENDOCRINOLOGY | ||||||
| 07/15/2022 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $18.46 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 30 | 3,263 | 8,761 | $1.1M | $249,531 |
| 2022 | 21 | 2,620 | 3,790 | $840,193 | $176,856 |
| 2021 | 23 | 2,798 | 4,145 | $870,975 | $197,809 |
| 2020 | 32 | 2,807 | 4,146 | $793,756 | $184,509 |
All Medicare Procedures & Services
106 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 432 | 588 | $238,746 | $53,395 | 22.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 648 | 776 | $222,735 | $48,692 | 21.9% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 123 | 145 | $107,159 | $25,354 | 23.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 162 | 162 | $85,865 | $18,970 | 22.1% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 21 | 141 | $87,122 | $18,872 | 21.7% |
| 52601 | Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | Facility | 2023 | 22 | 22 | $51,899 | $12,541 | 24.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 117 | 125 | $53,379 | $12,496 | 23.4% |
| J9030 | Bcg live intravesical instillation, 1 mg | Office | 2023 | 12 | 4,100 | $41,095 | $9,082 | 22.1% |
| 51700 | Simple bladder irrigation and/or instillation | Office | 2023 | 101 | 152 | $38,157 | $6,071 | 15.9% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2023 | 889 | 1,478 | $14,824 | $5,804 | 39.1% |
| 51720 | Instillation of anti-cancer drug into bladder | Office | 2023 | 13 | 84 | $23,691 | $5,638 | 23.8% |
| 52310 | Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | Office | 2023 | 14 | 17 | $16,865 | $4,211 | 25.0% |
| 52356 | Crushing of stone of ureter with insertion of stent using an endoscope | Facility | 2023 | 12 | 13 | $17,472 | $3,937 | 22.5% |
| 52235 | Destruction and/or removal of growth of bladder and urethra using an endoscope, 2.0-5.0 cm | Facility | 2023 | 13 | 17 | $15,845 | $3,581 | 22.6% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 324 | 427 | $25,633 | $3,210 | 12.5% |
| 55700 | Biopsy of prostate gland | Office | 2023 | 14 | 14 | $11,130 | $2,487 | 22.3% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 88 | 138 | $9,664 | $2,059 | 21.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 13 | 13 | $7,397 | $1,622 | 21.9% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2023 | 14 | 15 | $6,450 | $1,559 | 24.2% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2023 | 13 | 13 | $18,213 | $1,536 | 8.4% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 29 | 39 | $4,681 | $1,507 | 32.2% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 23 | 51 | $5,153 | $1,290 | 25.0% |
| 76857 | Limited ultrasound scan of pelvis | Office | 2023 | 38 | 38 | $5,663 | $1,280 | 22.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 13 | 13 | $4,615 | $928.84 | 20.1% |
| 76942 | Ultrasonic guidance for needle placement | Office | 2023 | 18 | 20 | $3,641 | $904.00 | 24.8% |
About Dr. Christopher Moore, M.D
Dr. Christopher Moore, M.D is a Urology healthcare provider based in Orange Park, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1669552030.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Moore, M.D has received a total of $3,565 in payments from pharmaceutical and medical device companies, with $514.57 received in 2024. These payments were reported across 108 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($3,550).
As a Medicare-enrolled provider, Moore has provided services to 11,488 Medicare beneficiaries, totaling 20,842 services with total Medicare billing of $808,706. Data is available for 4 years (2020–2023), covering 106 distinct procedure/service records.
Practice Information
- Specialty Urology
- Location Orange Park, FL
- Active Since 10/17/2006
- Last Updated 09/09/2009
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1669552030
Products in Payments
- XTANDI (Drug) $375.94
- MYRBETRIQ (Drug) $281.46
- Cook Medical Stents (Device) $221.70
- CVAC ASPIRATION SYSTEM (Device) $140.65
- Flex-X (Device) $137.47
- RESONANCE (Device) $135.86
- COOK MEDICAL DILATION/ACCESS (Device) $127.30
- Urolift - UL400 (Device) $122.65
- XLIF (Device) $122.22
- GENERAL - ERECTILE DYSFUNCTION (Device) $116.11
- Axonics (Device) $114.75
- TITAN (Device) $107.30
- COOK (Device) $101.40
- COOK MEDICAL UROLOGY (Device) $100.00
- XIAFLEX (Biological) $97.81
- VRAYLAR (Drug) $90.51
- Xtandi (Drug) $80.45
- Prolia (Biological) $64.17
- UroLift (Device) $54.29
- AVEED (Biological) $44.86
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Orange Park
Mrs. Maryann Kenneson, M.d, M.D
Urology — Payments: $7,393
Dr. Marc Blasser, M.d, M.D
Urology — Payments: $5,925
Dr. David Bargnesi, Md, MD
Urology — Payments: $4,730
Robert Marino, M.d, M.D
Urology — Payments: $619.43
Dr. James Kaelin, M.d, M.D
Urology